Re-evaluating Trauma Care: Does a Whole Blood Transfusion Save More Lives?

A massive analysis of nearly 50,000 trauma patients shows that administering intact blood, rather than separated parts, reduces 24-hour mortality by 4.6 percentage points in civilian settings. Proving the efficacy of a whole blood transfusion was difficult because trauma populations are highly heterogeneous and resuscitation protocols vary wildly between hospitals.

The whole blood transfusion debate

For decades, trauma centres have relied on component therapy. This method separates donated blood into red cells, plasma, and platelets, allowing doctors to target specific deficits. However, a whole blood transfusion provides an immediate, balanced physiological replacement for massive haemorrhage. The question has always been whether keeping the blood intact actually improves survival rates over mixing the components back together at the bedside.

What the data measured

Researchers aggregated 40 studies spanning from 2006 to 2025. They measured 24-hour mortality, 30-day mortality, and overall transfusion requirements. The data showed a distinct divide between civilian and military outcomes. In civilian hospitals, whole blood reduced both 24-hour and 30-day mortality compared to component therapy. Furthermore, these patients required fewer total units of blood. Conversely, the five studies focusing on military settings measured no survival benefit. The odds ratio for military trauma sat at 0.99, suggesting identical outcomes between the two methods.

Unanswered questions and limitations

Despite the large sample size, the study does not solve the problem of standardising patient selection. The researchers noted wide prediction intervals, meaning the true effect varies considerably depending on the specific hospital and protocol. We still do not know exactly which subgroups of civilian patients benefit the most, nor why the military data showed no improvement. The reliance on observational data for 38 of the 40 studies also introduces potential bias.

Future outlook

The evidence supports adopting whole blood protocols in civilian trauma centres. Yet, the high heterogeneity dictates that hospitals must proceed carefully. Future clinical trials must focus on:

• Identifying the exact patient profiles that benefit most from intact blood.
• Investigating why military trauma responds differently to civilian trauma.
• Standardising delivery protocols across different medical facilities.